Adiponectin: An Indicator for Metabolic Syndrome

Background: Metabolic syndrome (MetS), a cluster of cardiometabolic risk factors, consider as a manifestation of obesity. However, a proportion of obese patients do not develop MetS. The aim of our study was to determine whether concentration of plasma adiponectin and leptin differ between metabolic...

Full description

Saved in:
Bibliographic Details
Main Authors: Somaye YOSAEE (Author), Mahmoud KHODADOST (Author), Alireza ESTEGHAMATI (Author), John R. SPEAKMAN (Author), Kurosh DJAFARIAN (Author), Vida BITARAFAN (Author), Farzad SHIDFAR (Author)
Format: Book
Published: Tehran University of Medical Sciences, 2019-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a99a9f2a32a9483a8f4b11246d8d02eb
042 |a dc 
100 1 0 |a Somaye YOSAEE  |e author 
700 1 0 |a Mahmoud KHODADOST  |e author 
700 1 0 |a Alireza ESTEGHAMATI  |e author 
700 1 0 |a John R. SPEAKMAN  |e author 
700 1 0 |a Kurosh DJAFARIAN  |e author 
700 1 0 |a Vida BITARAFAN  |e author 
700 1 0 |a Farzad SHIDFAR  |e author 
245 0 0 |a Adiponectin: An Indicator for Metabolic Syndrome 
260 |b Tehran University of Medical Sciences,   |c 2019-06-01T00:00:00Z. 
500 |a 10.18502/ijph.v48i6.2921 
500 |a 2251-6085 
500 |a 2251-6093 
520 |a Background: Metabolic syndrome (MetS), a cluster of cardiometabolic risk factors, consider as a manifestation of obesity. However, a proportion of obese patients do not develop MetS. The aim of our study was to determine whether concentration of plasma adiponectin and leptin differ between metabolic unhealthy obese (MUO) patients and comparable age- and sex-matched control groups. Methods: In this case-control study, we assigned 51 obese patients with MetS (MUO) in cases group and 102 metabolic healthy obese (MHO) and normal weight metabolic healthy subjects matched for age and gender to cases in control groups. The study was conducted between December 2014 and February 2016 in the Endocrinology Research Center of Tehran University of Medical Sciences , Tehran , Iran.  We measured serum adiponectin, leptin, their ratio, and body composition in all subjects. Results: No significant differences were observed between MHO and MUO in term of total fat mass and trunk fat (P>0.05). Compared to MHO and normal weight metabolic healthy subjects, MUO subjects had lower levels of plasma adiponectin (P<0.001) and lower plasma adiponectin to leptin ratio (P<0.001) and a higher level of plasma leptin (P<0.002). A Receiver Operator Characteristic curve was used to identify the ability of adiponectin and leptin level to predict the MetS. The area under the Receiver Operator Characteristic curve was 0.66 (P<0.01), 0.73 (P<0.001) and 0.75 (P<0.001) for leptin, adiponectin, and adiponectin/leptin ratio levels respectively. Conclusion: Our study introduced adiponectin and leptin as indicator of MetS and obesity respectively. 
546 |a EN 
690 |a Leptin 
690 |a Adiponectin 
690 |a Metabolic syndrome 
690 |a Fat mass 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Iranian Journal of Public Health, Vol 48, Iss 6 (2019) 
787 0 |n https://ijph.tums.ac.ir/index.php/ijph/article/view/17349 
787 0 |n https://doaj.org/toc/2251-6085 
787 0 |n https://doaj.org/toc/2251-6093 
856 4 1 |u https://doaj.org/article/a99a9f2a32a9483a8f4b11246d8d02eb  |z Connect to this object online.